The US Department of Defense, Defense Health Agency seeks vendors to supply cost-per-reportable results for clinical laboratory reagents and consumables for hematology, urinalysis, and clinical chemistry with immunoassay testing. The requirement entails a comprehensive package including analyzers, technology, and support services for Naval Hospital Camp Pendleton. With a base period of 12 months and four 12-month options, it offers a comprehensive approach to clinical testing.
The agency seeks a complete solution for efficient laboratory operations, including quality control, training, and technical maintenance, with all costs factored into the CPPR model. Vendors must carefully review the SOW and Provisions and Clauses attachments for a detailed understanding of the requirement, and respond with a quote by the deadline for consideration.
Clinical laboratories require these analytical tools and consumables for efficient operation, playing a crucial role in patient care and health monitoring within the military healthcare system. The contract, valued at an estimated $7 million, seeks a cost-effective and reliable solution while improving healthcare outcomes for military personnel.
Quotes are due by 10:00 AM Pacific Time on August 8, 2024, with key contacts provided for CHA-ON Gordon and Kennette Esguerra for further clarification.